|
Re: The 34.4 million
|
2
|
Zenith Epigenetics
|
Dec 06, 2015 02:00PM
|
|
Re: Another country listed on EU Clinical Trial Register for BETonMACE
|
7
|
Resverlogix Corp.
|
Dec 10, 2015 03:04PM
|
|
Newco Ownership
|
3
|
Zenith Epigenetics
|
Dec 10, 2015 03:31PM
|
|
Re: Another country listed on EU Clinical Trial Register for BETonMACE
|
8
|
Resverlogix Corp.
|
Dec 10, 2015 08:24PM
|
|
Re: Newco Ownership
|
3
|
Zenith Epigenetics
|
Dec 11, 2015 12:13PM
|
|
Re: What if...?
|
4
|
Zenith Epigenetics
|
Dec 12, 2015 11:43AM
|
|
Re: What if...?
|
5
|
Zenith Epigenetics
|
Dec 12, 2015 12:38PM
|
|
Re: AGM - High Level Summary
|
7
|
Zenith Epigenetics
|
Jan 07, 2016 11:57PM
|
|
Re: AGM - High Level Summary
|
3
|
Zenith Epigenetics
|
Jan 08, 2016 12:06AM
|
|
Re: CRISPR vs. BET inhibitors
|
3
|
Resverlogix Corp.
|
Jan 10, 2016 06:16PM
|
|
Re: CRISPR vs. BET inhibitors
|
2
|
Resverlogix Corp.
|
Jan 10, 2016 11:10PM
|
|
Re: AGM - High Level Summary
|
3
|
Zenith Epigenetics
|
Jan 12, 2016 05:38PM
|
|
Re: AGM - High Level Summary
|
5
|
Zenith Epigenetics
|
Jan 12, 2016 08:25PM
|
|
Re: AGM - High Level Summary
|
5
|
Zenith Epigenetics
|
Jan 12, 2016 10:14PM
|
|
Re: AGM - High Level Summary
|
5
|
Zenith Epigenetics
|
Jan 13, 2016 01:37PM
|
|
Re: AGM - High Level Summary
|
1
|
Zenith Epigenetics
|
Jan 13, 2016 02:01PM
|
|
otcbb
|
3
|
Zenith Epigenetics
|
Jan 18, 2016 09:00AM
|
|
Re: RVX/Zenith Financial Statement Disparity - Royalty Preferred Shares
|
3
|
Resverlogix Corp.
|
Jan 22, 2016 06:21PM
|
|
Re: Liquidity
|
4
|
Zenith Epigenetics
|
Jan 22, 2016 06:36PM
|
|
Re: RVX/Zenith Financial Statement Disparity - Royalty Preferred Shares
|
4
|
Resverlogix Corp.
|
Jan 23, 2016 12:43PM
|
